Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis by Pai, Saparna et al.
Real-Time Imaging Reveals the Dynamics of Leukocyte
Behaviour during Experimental Cerebral Malaria
Pathogenesis
Saparna Pai1,2*, Jim Qin1, Lois Cavanagh1,2, Andrew Mitchell1, Fatima El-Assaad3, Rohit Jain1,2,
Valery Combes2,3, Nicholas H. Hunt2,4, Georges E. R. Grau2,3, Wolfgang Weninger1,5,6*
1 Immune Imaging Laboratory, The Centenary Institute, Newtown, Sydney, New South Wales, Australia, 2 Sydney Medical School, University of Sydney, Sydney, New South
Wales, Australia, 3 Vascular Immunology Unit, Discipline of Pathology, Sydney Medical School, University of Sydney, Camperdown, Sydney, New South Wales, Australia,
4Molecular Immunopathology Unit, Discipline of Pathology, Sydney Medical School and Bosch Institute, University of Sydney, Camperdown, Sydney, New South Wales,
Australia, 5Discipline of Dermatology, University of Sydney, Sydney, New South Wales, Australia, 6Department of Dermatology, Royal Prince Alfred Hospital,
Camperdown, Sydney, New South Wales, Australia
Abstract
During experimental cerebral malaria (ECM) mice develop a lethal neuropathological syndrome associated with
microcirculatory dysfunction and intravascular leukocyte sequestration. The precise spatio-temporal context in which the
intravascular immune response unfolds is incompletely understood. We developed a 2-photon intravital microscopy (2P-
IVM)-based brain-imaging model to monitor the real-time behaviour of leukocytes directly within the brain vasculature
during ECM. Ly6Chi monocytes, but not neutrophils, started to accumulate in the blood vessels of Plasmodium berghei ANKA
(PbA)-infected MacGreen mice, in which myeloid cells express GFP, one to two days prior to the onset of the neurological
signs (NS). A decrease in the rolling speed of monocytes, a measure of endothelial cell activation, was associated with
progressive worsening of clinical symptoms. Adoptive transfer experiments with defined immune cell subsets in
recombinase activating gene (RAG)-1-deficient mice showed that these changes were mediated by Plasmodium-specific
CD8+ T lymphocytes. A critical number of CD8+ T effectors was required to induce disease and monocyte adherence to the
vasculature. Depletion of monocytes at the onset of disease symptoms resulted in decreased lymphocyte accumulation,
suggesting reciprocal effects of monocytes and T cells on their recruitment within the brain. Together, our studies define
the real-time kinetics of leukocyte behaviour in the central nervous system during ECM, and reveal a significant role for
Plasmodium-specific CD8+ T lymphocytes in regulating vascular pathology in this disease.
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Introduction
CM is a severe complication of Plasmodium falciparum infection
and is responsible for an estimated 627,000 deaths annually,
particularly among children [1]. CM is strongly associated with
parasitised red blood cell (pRBC) sequestration in the vasculature
of the brain [2,3]. The resultant obstruction of blood flow has been
proposed as a potential pathological mechanism leading to
ischemia and hypoxia of the central nervous system (CNS)
[4,5,6]. Although direct visualisation of the retinal vasculature in
infected humans supports this notion [7], most neuropathological
observations in humans are limited to post-mortem analysis of
brain tissues. In addition, imaging approaches such as MRI do not
resolve details of microcirculatory dysfunction or neuropathology
in the intact brain [6,8]. Therefore, we lack a dynamic view of the
events leading to progressive CNS damage during CM.
The murine model of PbA-infection has proven useful in
studying ECM pathogenesis [9,10,11,12]. In the PbA model,
leukocytes accumulate in the brain microcirculation when mice
develop NS, similarly to human disease [12,13,14,15]. However,
to date no detailed real-time microscopic investigations have been
conducted to assess the spatio-temporal dynamics of leukocyte
behaviour in the brain during ECM development. Leukocyte
imaging has been limited to visualising circulating cells using non-
specific dyes or fluorescent antibodies [16,17]. Thus, it is not
known whether and how local inflammation within the brain
microvasculature correlates with disease progression, and what
factors control the sequestration of leukocytes in the blood vessels.
In the present work, we used 2P-IVM [18] to quantitate and
characterize specific leukocyte subsets in situ within the brain
microvasculature in a dynamic manner.
Observations that athymic nude mice are protected from CM
have implicated T cells in the pathogenesis of disease [19]. Indeed,
several studies have documented that the CD8+ T cell subset does
not protect but rather promotes NS during PbA infection. Mice
depleted of or deficient in CD8+ T cells, b2-microglobulin,
perforin or granzyme B are all protected from ECM establishing
the role of effector T cell cytotoxicity in its pathogenesis
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[9,13,20,21,22,23]. Further, antigen-specific cytotoxic T lympho-
cytes (CTL) sequester within the brain vasculature where they
produce granzyme B to promote NS [20,21,24]. Nevertheless, the
precise effects of CD8+ T cells on vascular neuropathology during
CM are not entirely clear.
The primary goal of this study was to investigate the time-
dependent development of vascular neuropathology during ECM
in situ using 2P-IVM and to dissect the role of CD8+ T cells in
regulating leukocyte trafficking within the CNS. Our study
describes some of the precise events that lead up to vascular
neuropathology during ECM development. We show that
monocytes are a prominent cell type adhering to the microvas-
culature of the brain during ECM. These cells enhance
recruitment of CD4+ and CD8+ T cells to the CNS vasculature
but are not essential for disease. Further, we show that adhesive
behaviour and rolling velocity of monocytes change depending on
the disease stage and are regulated by the presence of Plasmodium-
specific CD8+ T cells, which in contrast, are crucial for driving
clinical disease.
Results
Ly6Chi monocytes and CD8+ T lymphocytes sequester in
the brain during ECM
To characterize and quantify brain sequestered leukocytes
(BSL) during ECM, we performed flow cytometric analysis of
brain single cell suspensions harvested from uninfected (UI) and
PbA-infected C57BL/6 mice. PbA-infected mice included in this
analysis had all developed NS (see Materials and Methods and Fig.
S1 for disease scoring). CD11b+Ly6G2Ly6Chi monocytes consti-
tuted 15.561.5% of total CD45hi BSL in PbA-infected mice as
compared to 4.360.6% in uninfected mice (Fig. S2A, C). CD8+ T
cells constituted 51.962.6% and 10.961.7% and CD4+ T cells
6.460.7% and 9.361.5% of total CD45hi BSL in PbA-infected
and uninfected mice, respectively (Fig. S2B, C). This translated to
a 33-fold increase in absolute monocyte numbers and a 66-fold
and 8-fold increase in absolute CD8+ T and CD4+ T cell numbers,
respectively, in PbA-infected mice (Fig. 1). CD8+ T cell numbers
were 9-fold higher than CD4+ T cells in PbA-infected mice. No
change in neutrophils and NK cell numbers was observed (Fig. 1).
Collectively, our data are consistent with previous reports showing
that there is a significant increase in the number of Ly6Chi
monocytes [25] and CD8+ T cells, and to a lesser degree CD4+ T
cells [13,15,21,26] recruited to the brain during ECM.
An improved methodology for visualizing leukocyte
trafficking during ECM
We have recently established an intravital imaging model that
allows us to visualize the superficial intact pial vasculature in living
mice in situ (Fig. S3) [27]. In order to gain a better understanding
of how leukocytes contribute to vascular inflammation during
ECM, we adopted this approach for mice infected with PbA. The
main obstacle with imaging ECM is that, often, mice may progress
to severe disease within only a few hours thereby leaving a short
time window for surgical preparation and intravital imaging. We
therefore opted for an open skull preparation, whereby a cranial
window is prepared by skull bone removal under the least possible
traumatic conditions and the shortest possible time frame
(,70 min). We observed that mice that developed NS resisted
anaesthetic action. To overcome this, we allocated increased
anaesthesia time for infected mice (3 times longer than healthy
mice). Further, mice with an NS score of ,7 were largely selected
for our studies because these mice tolerated anaesthesia, surgical
procedure and intravital imaging. A template for anaesthesia
monitoring is provided in Table S1. Our procedure was further
optimized for providing lasting pain relief with buprenorphine, a
non-steroidal opiate that has no known immunosuppressive
function [27]. This is important as the immunosuppressive action
of other anti-inflammatory drugs and analgesics potentially
interferes with the development of immune responses during
ECM [28]. Mice were maintained at a core body temperature of
37uC in order to obviate the introduction of artefacts during the
surgical procedure and intravital imaging, as reported [27]. Core
body temperature was regulated by using a heat pad connected to
a rectal probe and covering mice with a thermal blanket. For
uniformity in imaging conditions, mice with ECM were main-
tained under the same optimised conditions as healthy mice.
Under these conditions, mice with ECM did not develop
hypothermia, which is normally observed during the progression
of disease [29].
Leukocyte accumulation occurs in a stage dependent
manner during ECM
To determine the kinetics of vascular leukocyte accumulation in
the course of ECM, we made use of MacGreen transgenic reporter
mice in which GFP expression in the circulation is confined mainly
to monocytes and granulocytes [30,31]. GFP expression can also
be seen in other immune cells in the brain parenchyma [30,31]
such as perivascular myeloid cells. MacGreen mice were infected
with PbA and monitored for clinical signs of ECM. MacGreen6
RAG2/2 mice, which were derived by crossing MacGreen mice
with lymphocyte deficient RAG-12/2 mice [32], were also
infected with PbA. PbA-infected MacGreen6RAG2/2 mice did
not develop any severe clinical signs at the pre-defined clinical
end-point of day 7 p.i., as reported previously [24,33], and served
as a negative control (Fig. 2A). On the other hand, 65% of the
PbA-infected MacGreen mice that had developed minor clinical
signs on day 5–6 p.i. (early stage, ES) progressed on to develop
severe clinical signs (NS) on day 7 p.i. (Fig. 2A, B). Mean
parasitemia levels progressively increased in MacGreen mice
(Fig. 2C) with levels peaking on day 7 p.i. (p,0.005). Peak
Author Summary
Cerebral malaria (CM) is a severe complication of Plasmo-
dium falciparum infection that takes a significant toll on
human life. Blockage of the brain blood vessels contributes
to the clinical signs of CM, however we know little about
the precise pathological events that lead to this disease. To
this end, studies in Plasmodium-infected mice, that also
develop a similar fatal disease, have proven useful. These
studies have revealed an important role for leukocytes not
so much in protecting but rather promoting pathology in
the brain. To better understand leukocyte behaviour
during experimental CM, we established a brain-imaging
model that allows us to ‘peek’ into the brain of living mice
and watch immunological events as they unfold. We found
that worsening of disease was accompanied by an
accumulation of monocytes in the blood vessels. Mono-
cyte accumulation was regulated by activated CD8+ T cells
but only when present in critical numbers. Monocyte
depletion resulted in reduced T cell trafficking to the brain,
but this did not result in improved disease outcome. Our
studies reveal the orchestration of leukocyte accumulation
in real time during CM, and demonstrate that CD8+ T cells
play a crucial role in promoting clinical signs in this
disease.
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parasitemia in MacGreen mice was not significantly different
(p = ns) from that of MacGreen6RAG2/2 mice on day 7 p.i.
We then used 2P-IVM to track the behaviour of GFP+
leukocytes in PbA-infected MacGreen mice in the three experi-
mental groups (UI, ES and NS). First, a baseline value of the
average number of rolling and firmly adherent GFP+ cells in the
vasculature of UI mice was determined. Rolling cells were defined
as single, round-shaped endothelium-interacting cells moving in
the direction of the blood flow at a lower speed than free flowing
cells. In UI mice, circulating cells were mostly non-interactive,
with leukocytes largely adhering at a baseline value of 0–300
cells/mm2 min21. Next we arbitrarily graded leukocyte accumu-
lation in the diseased animals relative to UI mice as follows: nil (0–
300 cells/mm2 min21, in the same range as UI), moderate (300–
1000 cells/mm2 min21) and severe (1000–10,000 cells/
mm2 min21) interactions. Examples of the different grades are
shown in Fig. 2D–F (Movies S1, S2, S3). To assess leukocyte
accumulation during ES, mice with minor clinical signs were
assessed on day 5–6 p.i. We found that 31% of venules had
moderate and 15% had severe levels of leukocyte accumulation
during ES (Fig. 2G). With the onset of NS, leukocyte accumulation
further increased with 10% of venules showing moderate and 79%
showing severe levels (Fig. 2G). This was paralleled by an increase
in the absolute number of endothelium-interacting GFP+ leuko-
cytes in the CNS vasculature, with cells rolling along (116660
cells/mm2 min21) or adhering to the endothelium (283674/mm2)
as early as day 5–6 p.i. (Fig. 2H). With the progression of disease
from ES to NS, the number of adherent leukocytes increased
significantly to an average of 14326200/mm2, while rolling cell
numbers did not change (Fig. 2H).
GFP+ leukocytes interacting with the vascular
endothelium are monocytes
To determine the lineage of GFP+ leukocytes that accumulate in
the venules of MacGreen mice during NS, we administered
antibodies against Ly6C or Ly6G or an isotype control antibody
intravenously (i.v.) [34]. The Gr1 and Ly6C surface markers are
expressed by both GFP+ granulocytes and monocytes, whereas
Ly6G is expressed selectively by neutrophils. We found that the
adherent GFP+ leukocytes did not stain for the isotype control
(Fig. 3A) (Movie S4), but that the majority were Ly6C+ (Fig. 3B)
(Movie S5). Several rolling leukocytes also stained for Ly6C.
Stationary Ly6G+ cells were not seen (Fig. 3C) (Movie S6). We
validated the used antibodies also in an ear skin-imaging model in
Lysozyme-GFP mice, where GFP+ neutrophils are known to roll
along non-inflamed dermal post-capillary venules [34,35], unlike
the non-inflamed pial vasculature where such events are almost
entirely absent [36]. While no staining was observed with the
isotype control (Fig. 3D) (Movie S7), GFP+ cells were positive for
both Ly6C (Fig. 3E) (Movie S8) and Ly6G (Fig. 3F) (Movie S9).
Further confirmation of the identity of adherent GFP+ cells was
obtained with antibody staining of brain sections (Fig. S4). Thus,
along with the flow cytometric data presented in Fig. 1, these
results show that the adherent GFP+ cells in the CNS vasculature
during ECM are Ly6Chi monocytes.
Concomitantly with increased monocyte adherence, we ob-
served a transient decrease in total circulating monocyte numbers
during ES, which was restored during the later NS (Fig. 3G).
Notably, Ly6Clo monocytes largely disappeared from the circula-
tion, corresponding with a shift towards a Ly6Chi subset (Fig. 3G,
H). Our data show that there is an overall switch to Ly6Chi
monocytes within circulation during infection, and this translates
to increased adherence to the vascular endothelium of the brain
during ECM.
Quantification of monocyte rolling and adherence in the
course of ECM
As another measure of endothelial cell activation during ECM
development, we measured rolling velocities of GFP+ cells in
MacGreen mice. As reported, GFP+ cells were largely non-
interactive in UI animals [36], whereas during ES they were
observed rolling along the endothelium (Fig. S5A; Vmean:
22.961.3 mm/sec); which is within the range of rolling velocities
described for leukocytes in other vascular beds (20–60 mm/sec)
[37]). During NS, the majority of the GFP+ cells became firmly
adherent, with the remaining rolling cells slowing down consid-
erably (Vmean: 6.361.8 mm/sec; Fig. S5B). Three representative
tracks that depict the instantaneous velocities of monocytes during
ES and NS are shown in Fig. S5C and D. The average velocity of
rolling monocytes in severely inflamed venules (Vmean:
4.761.2 mm/sec) was significantly lower than that in moderately
inflamed venules (Vmean: 23.061.3 mm/sec) (Fig. S5E).
Studies have shown that myelomonocytic cell recruitment by
CTL and their extravasation leading to CNS injury plays an
Figure 1. Monocytes and CD8+ T lymphocytes accumulate in the brain during ECM. Uninfected and PbA-infected C57BL/6 mice with NS
were sacrificed on day 7 p.i. and brains harvested. Quantitative analysis of BSL is shown. Symbols represent individual animals. Bars represent the
geometric mean. Data are a mean of 5 mice per group (n = 5). Monocytes [23096489 versus 77,340623090], Neutrophils [543261898 versus
824261928], CD8+ T lymphocytes [552061573 versus 365,9606134,268], CD4+ T lymphocytes [479261381 versus 40,240611,872] and NK cells
[748062235 versus 17,87465262]. ns, not significant, **p,0.001, ****P,0.0001 (Unpaired t test).
doi:10.1371/journal.ppat.1004236.g001
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Figure 2. Visualizing the behaviour of GFP+ leukocytes in the brain microvasculature. PbA-infected MacGreen (n = 16) and
MacGreen6RAG2/2 mice (n = 4) were monitored for (A) % survival to pre-defined clinical endpoint, (B) clinical score of each mouse on day 5–7
p.i., *p,0.05, ns, not significant (Mann-Whitney test), or (C) % parasitemia (n = 4 mice/group), ns, not significant, *p,0.05, **p,0.005 (One way
ANOVA, Tukey’s multiple comparisons test). Each symbol in (B) represents one mouse. Data are a mean of 3–6 independent experiments. MacGreen
mice underwent intravital imaging of the brain microvasculature at various stages including when mice were uninfected (UI) (n = 4 mice), during ES
on day 5–6 p.i. (n = 5 mice) and after they developed NS on day 7 p.i. (n = 3 mice). (D), (E), (F) Representative snapshots of 3–5 independent intravital
imaging experiments shows nil, moderate and severe levels of leukocyte accumulation. Migratory paths of GFP+ leukocytes are shown as purple
Imaging Leukocyte Responses during Cerebral Malaria
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important role in viral infection [38]. Therefore we asked whether
monocytes also extravasated during ECM. We did not observe
extravasation events of rolling/adhering monocytes during the
observation period of up to 1.5 hours (Fig. S6A) (Movie 10). GFP+
cells typically travelled in the same direction as that of the blood
flow (Fig. S6B) and exhibited very little deviation from their path
during ES or NS as evident from the meandering index [MI] [ES:
0.9260.01] [NS: 0.8760.02] (Fig. S6C). To further immunophe-
notype GFP+ cells residing in the perivascular space of UI and
PbA-infected MacGreen and MacGreen6RAG2/2 mice, we used
confocal microscopy (Panel i–iii, Fig. S6D). We injected wheat
germ agglutinin (WGA) conjugated to Alexa 594 to mark
circulating monocytes [39], and then prepared sections of the
brain. Round GFP+ WGA+ intravascular monocytes were mostly
F4/802/lo (yellow overlay) whereas stellate-shaped GFP+ perivas-
cular cells were mostly F4/80+ (blue-green overlay). We concluded
that monocytes by and large do not extravasate in the course of
ECM, which is consistent with our previous histopathological
studies [3,40]. GFP+ cells in the perivascular space most likely
represent perivascular macrophages in MacGreen mice [41,42].
Primed CD8+ T cells induce NS in immunodeficient
RAG2/2 mice and promote high levels of monocyte
accumulation in the brain microvasculature
The role of CD8+ T cells in promoting CM is well established
[13,15,21,24,43,44]. Therefore, we investigated whether CD8+ T
cells regulate monocyte accumulation in mice during ECM. To
this end, MacGreen and MacGreen6RAG2/2 mice were infected
with PbA or left uninfected. In MacGreen6RAG2/2 mice,
approximately 21% of the venules had moderate and 8% had
severe levels of monocyte accumulation (Fig. S7A, B), with the
total numbers of endothelium-interacting monocytes averaging
332 (674.5)/mm2 min21 as compared to MacGreen mice with
1432 (6200)/mm2 min21 interacting cells (Fig. S7C, p,0.0001).
To directly examine the effects of T lymphocyte subsets on ECM
development, we adoptively transferred enriched CD8+ (80%) or
CD82 splenocytes isolated from UI or PbA-infected C57BL/6
donor mice into MacGreen RAG2/2 recipients (Fig. 4A, B).
When MacGreen6RAG2/2 recipient mice were infected with
PbA (Fig. 4A), we found that CD8+ T cells from PbA-infected
donor mice induced severe clinical signs in all animals (Fig. 4C, D,
E). Recipients of primed CD8+ T cells had a higher mean clinical
score compared to all other groups, at least during the observation
period of 7 days (Fig. 4C). Uninfected recipients that received
primed CD8+ T cells did not develop ECM (data not shown). Of
recipients receiving naı¨ve T cells, 25% developed severe clinical
signs, whereas all other groups of recipients were resistant (Fig. 4D,
E).
To determine the effects of T cells on monocyte behaviour
within the brain vasculature, we performed 2P-IVM on groups of
MacGreen6RAG2/2 mice that had received saline, CD82
splenocytes, naive CD8+ T cells or primed CD8+ T cells
(Fig. 4A). The four recipient groups were infected with PbA and
blood vessels assessed by intravital imaging on day 7 p.i. As in
wildtype MacGreen mice, several degrees of monocyte accumu-
lation could be observed in the various groups of MacGreen6
RAG2/2 recipient mice (representative examples of nil, moderate
and severe accumulation are shown in (Fig. 5A–C) (Movie S11,
S12, S13). As expected, saline infusion alone resulted in low levels
of inflammation (Fig. 5D). Adoptive transfer of CD82 splenocytes
from PbA-infected recipients resulted in an average 46% and 22%
of venules showing moderate and severe levels of GFP+ cell
accumulation, respectively. Transfer of naı¨ve CD8+ T cells
resulted in 40% of venules showing moderate, and 35% showing
severe levels of GFP+ cell adhesion. Primed CD8+ T cells induced
an average of 37% of venules showing moderate and an average of
52% showing severe levels of monocyte accumulation. In terms of
absolute numbers of GFP+ cells adhering to the vessel wall, saline
alone or CD82 splenocytes only induced low levels of monocyte
accumulation (332674/mm2 and 479668/mm2 respectively)
(Fig. 5E). Adoptive transfer of naı¨ve CD8+ T cells did not change
the phenotype significantly from that induced by saline or CD82
splenocytes with monocytes adhering to the endothelium at
7676117.7/mm2. On the other hand, primed CD8+ T cells led
to significantly more monocytes adhering within the vasculature
compared to groups receiving other treatments, at an average of
15136225.2/mm2 (Fig. 5E). Mice with this phenotype developed
NS. Rolling cell numbers did not change between the three groups
(Fig. 5F). Transfer of primed CD8+ T cells caused monocytes to
slow down considerably as compared to naı¨ve CD8+ T cells (not
shown). The average velocity of rolling monocytes in severely
inflamed venules (Vmean: 18.961.03 mm/sec) was lower than in
moderately inflamed venules (Vmean: 29.962.2 mm/sec) (Fig. S8).
Collectively, our data show that the clinical signs of NS induced by
primed CD8+ T cells are associated with high levels of monocyte
accumulation in venules as well as slowing down of the rolling
monocytes.
Next, to determine the critical number of primed effector CTL
that are required to induce monocyte adhesion and disease, we
performed dose titration experiments. Primed CD8+ T cells (10,
4.5, 3 and 06106) were transferred into PbA-infected Mac-
Green6RAG2/2 recipients and on day 7 p.i., the blood vessels in
each of the four groups were assessed by intravital imaging. Mice
that received 4.5, 3 and 06106 T cells did not develop NS (Fig.
S9A) with approximately 23% and 50% of venules lacking
monocyte accumulation in mice that received 4.56106 and 36106
T cells respectively (Fig. S9B). In contrast, 106106 CTL
consistently induced NS, with only 11% venules lacking monocyte
accumulation. Of interest, recipients of 106106 naı¨ve CD8+ T
cells lacked monocyte accumulation in 25% of venules and were
also protected from NS (Fig. 5D). Furthermore, transfer of 406106
naı¨ve CD8+ T cells into PbA-infected MacGreen6RAG2/2 mice
failed to increase monocyte accumulation or induce NS (not
shown). Taken together, these data show that a critical number of
primed CD8+ T cells is required in order to induce high levels of
monocyte adhesion and clinical disease.
Monocyte depletion decreases CD8+ T cell recruitment
but does not alter disease course
Given the observation of inflammatory monocyte recruitment
to the brain during ECM, we investigated their role in the
development of neuropathology. Circulating monocytes, and other
tracks. Blood vessels are marked by infusion of TRITC-conjugated dextran. Blue represents second harmonic generation (SHG) signals from
extracellular matrix fibres. White arrows indicate direction of blood flow. Perivascular myeloid cells are indicated by red arrows. Scale bars represent
100 mm in (D), 60 mm in (E) and 28 mm in (F). (G) % blood vessels that have nil, moderate and severe levels of leukocyte accumulation in UI, ES and NS.
(H) Average number of rolling and adherent leukocytes per mm2 of endothelium. A total 89, 90 and 43 blood vessels were assessed for UI, ES and NS
groups, respectively. Number of blood vessels assessed per mouse: UI (14, 30, 28, 17), ES (14, 15, 23, 22, 16) and NS (12, 25, 6). Bars represent mean6
SEM. ns, not significant, *p,0.05, **p,0.005, ****P,0.0001 (Kruskal-Wallis-Test, Dunn’s multiple comparisons test).
doi:10.1371/journal.ppat.1004236.g002
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phagocytic populations that are in contact with the peripheral
blood, were depleted by i.v. injection of clodronate liposomes (CL)
[45] either at two days prior to infection (day 22), two days p.i.
(day +2), or 5 days (day +5) p.i. Administration of CL prior to
infection led to complete protection from ECM, with mice
ultimately succumbing to high parasitemia and low haematocrit
(Fig. 6A, 6B, S10A, S10B). There was no difference in disease
course between PbA-infected mice that were depleted of
monocytes at day +2 or day +5 p.i. when compared to vehicle
treated mice (Fig. 6A). Nevertheless, mice that received CL late in
the disease course (day +5) showed decreased recruitment of BSL
compared to sham-depleted controls. As expected, treatment with
CL resulted in an 80% decrease in brain-recruited monocytes
following CL treatment (Fig. 6C). In addition, CD4+ and CD8+ T
cells and NK cell numbers were also decreased by 1.8-fold, 2.8-
fold and 4.6-fold, respectively, compared to sham-treated control
animals, indicating the role of monocytes/macrophages in
lymphocyte recruitment to infected brain during ECM.
Discussion
Discussion on the type of leukocytes that sequester inside the
blood vasculature has gained significance due to discrepancies that
have been reported between the pathological features of the ECM
model and human CM [46]. A recent report tries to look beyond
the differences in the cell type that sequester to the endothelium
during human CM and ECM [47]. It attempts to unify the two by
suggesting that the outcome of the neuropathological syndrome
may be similar (i.e. impaired blood flow, altered hemodynamics
and tissue necrosis). A consensus has since emerged within the field
that experimental studies in the mouse model of ECM must be
directed towards understanding the pathological processes within
the brain that lead to NS and the relevance of these localised
events to human CM. As a step in this direction, we performed
real-time imaging of leukocyte behaviour in the CNS microvas-
culature in order to understand the role of leukocytes in ECM
development.
To achieve this, we optimised a brain-imaging model specifi-
cally designed for imaging mice with ECM [27]. Using this model
we assessed the dynamics of the leukocyte responses during ECM
in the absence of anti-inflammatory drugs. Another recent report
has utilized a chronic cranial window approach generated in
healthy mice 1–2 weeks before they develop ECM [48]. Anti-
inflammatory drugs were used to suppress inflammation induced
by the cranial window preparation on the basis that drug effects
will subside during the recovery period prior to imaging.
Nevertheless, anti-inflammatory drugs can potentially impact on
immune responses during the early stages of disease, given the
difficulties of maintaining a chronic cranial window in a drug-free
environment [49,50]. Another factor that significantly impacted
on the quality of intravital images was the anaesthetic state of
mice. Undoubtedly, intravital imaging studies in the ECM model
have been hampered until now due to technical difficulties [51]
such as anesthetising mice prior to surgery. To overcome this, a
majority of our recordings were acquired when mice were most
responsive to anaesthesia (mild clinical signs of ES on day 5–6 p.i.
or ,7 severe clinical signs of NS on day 7 p.i.). This strategy
increased the survival rate of mice during and after surgery and
obviated tracking cells within an immunosuppressed microenvi-
ronment.
Over the past decade, the role of CD8+ T cells in driving NS has
become well established, however the other populations of
leukocytes sequestering within the vasculature have not been
adequately characterised. Macrophages, neutrophils, CD4+ and
CD8+ T cells have all been reported to increase in numbers during
ECM [14,15]. While using T cell-deficient mice or depleting
CD8+ T cells in mice abrogated clinical signs and neuropathology
[13,19,20,52], depleting F4/80+ macrophages (with clodronate
liposomes) and antibody-mediated depletion of neutrophils in the
late stages of ECM failed to confer protection from NS [14,15].
This was further demonstrated using the MAFIA mice wherein
conditional ablation of about 80% of the total CD115+ myeloid
cells did not affect the parasite biomass in the head or prevent
ECM [53]. Similarly, depleting brain-sequestered FceRI+ granu-
locytes from day 5 p.i. did not protect mice from ECM although
this population was reported to play a crucial role in the lead up to
disease [54]. The above studies are contradicted by an earlier
report showing that BSL are not granulocytes but Ly6C+
monocytes, which also sequester to the endothelium of PbA-
infected mice that do not develop ECM [55,56]. Although no clear
functional role has been attributed to these leukocytes in inducing
NS, one study found that adherent leukocytes reduce the luminal
diameter of the blood vessels and function as barriers to blood flow
during ECM [57]. This is a reminder that functional studies can
sometimes be limited by a requirement for sensitive cellular and
imaging tools to help delineate complex mechanisms that
contribute to clinical disease. We therefore undertook a compre-
hensive phenotypic and functional analysis of leukocytes in the
CNS vasculature using multiple technical approaches. Our studies
show that the majority of the BSL are Ly6Chi monocytes or CD8+
T cells as assessed by flow cytometry with no increase in
granulocyte numbers. Thus, the molecules that promoted myeloid
cell adhesion to the vascular endothelium appear to be monocyte-
specific since neutrophils did not adhere, consistent with previous
reports [55]. Using intravital imaging, we further confirmed that
adherent leukocytes were Ly6C+Ly6G2 monocytes. Confocal
microscopy of whole mount brain sections revealed that the
intraluminal monocytes not only accumulated within the super-
ficial pial vessels but also in the deeper vessels of the cerebral
cortex (not shown).
Figure 3. Endothelium-interacting GFP+ leukocytes in the brain microvasculature are monocytes. PbA-infected MacGreen mice with NS
were injected i.v. with 5 mg of either (A) an isotype control, (B) anti-Ly6C (n = 2) or (C) anti-Ly6G antibody (n = 2) 1 hour prior to mice undergoing
intravital imaging of the brain microvasculature. Representative snapshots from each group are shown. Scale bars represent 30 mm in (A), 100 mm in
(B) and 58 mm in (C). Blue represents SHG signals from extracellular matrix fibres. White arrows indicate direction of blood flow. To aid orientation,
vascular walls are outlined. Cells stained with Ly6C antibody show an orange punctate stain that co-localises with GFP (red arrowheads = adherent
cells; yellow arrowheads = rolling cells). A total of 37, 29 and 45 blood vessels were assessed for the isotype control, Ly6C and Ly6G groups
respectively. Number of blood vessels per mouse: Isotype (n = 37), Ly6C (n = 14, 15) and Ly6G (n = 9, 36). Representative snapshots of intravital
imaging of the dermis of Lysozyme-GFP mice after injecting 5 mg of (D) an isotype control, (E) anti-Ly6C or (F) anti-Ly6G antibody, as reported [34].
Number of blood vessels per mouse: Isotype (n = 12), Ly6C (n = 11) and Ly6G (n = 11). Cells stained with Ly6C show a punctate stain as in the brain.
Cells stained with Ly6G have a red surface stain. Scale bars represent 60 mm in (D), 30 mm in (E) and 20 mm in (F). (G) Changes in blood monocyte
populations during ECM. Blood monocytes were quantified by flow cytometry after collection from either uninfected (UI) or PbA-infected mice that
had developed ES or NS (n = 4–5 mice/group). Symbols represent individual animals and bars represent means. *P,0.05, **p,0.01 (ANOVA with
Dunnett’s post-test vs. UI control). (H) Representative flow cytometric plots showing blood monocyte populations in UI, ES and NS mice. The
percentage of Ly6Clo and Ly6Chi monocytes are indicated. Data are from a single experiment (n = 4–5 mice/group).
doi:10.1371/journal.ppat.1004236.g003
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Studies have proposed that monocytes can transform into
macrophage-like antigen presenting cells within the blood vessels
and engage in intravascular antigen presentation to T cells [58].
Our data show that, during ECM, F4/802/lo monocytes remain
mostly single, round, discrete, non-vacuolated cells that can be
clearly distinguished from the stellate morphology of F4/80+
vacuolated, perivascular myeloid cells that flank the blood vessels
[30,31]. We are unable to formally exclude the possibility of
perivascular myeloid cells originating from extravasated mono-
cytes that underwent differentiation; however this is unlikely as
perivascular myeloid cells are detected in uninfected MacGreen
mice and their numbers did not increase significantly following
PbA-infection. Further, it is also unlikely that, during NS, all
monocytes that extravasate undergo differentiation into perivas-
cular myeloid cells within a short span of only a few hours.
Historically, leukocyte extravasation has not been documented in
Figure 4. An adoptive transfer model to study the regulation of monocytes during ECM. (A) CD8+ T cells or CD82 splenocyte fraction (Sp)
isolated by MACS from uninfected or PbA-infected C57BL/6 donor mice on day 7 p.i. were adoptively transferred into PbA-infected MacGreen6
RAG2/2 recipient mice as depicted. Only primed CD8+ T cells (red circle) isolated from PbA-infected C57BL/6 donor mice induce NS (orange
recipient). Representative data of 3 independent experiments is shown. (B) Dot plot shows purity of CD8+ T cells routinely obtained by MACS sorting.
(C) MacGreen6RAG2/2 recipient mice receiving saline (n = 4 mice), naı¨ve (n = 4 mice) or primed CD8+ T cells (n = 5 mice) or CD82 splenocytes (n = 4
mice) were infected with PbA and clinical scores monitored daily, *p = 0.01 (unpaired t test). (D) Clinical score of each mouse on day 5–7 p.i. Each
symbol represents one mouse. Recipients of naı¨ve and primed CD8+ T cells are shown in green and red respectively. (E) Percent survival of
MacGreen6RAG2/2 recipients after adoptive transfer, *p,0.05 (Mantel-Cox test).
doi:10.1371/journal.ppat.1004236.g004
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the ECM model and our histological studies support these
observations [3,40].
We observed that monocytes begin interacting with the
endothelium as early as day 5–6 p.i. when mice have only minor
clinical signs of ES. The factors that modulate the vascular
endothelium during ECM could thus be produced far earlier than
envisaged. As the disease progressed, we saw a shift in behaviour
with increasing numbers of monocytes adhering to the endothe-
lium of post-capillary venules. This was accompanied by a
significant decrease in the velocity of rolling monocytes. Vascular
Figure 5. Plasmodium-primed CD8+ T cells induce monocyte accumulation in MacGreen6RAG2/2mice. PbA-infected MacGreen6RAG2/2
mice that had received saline, CD82 splenocytes, naı¨ve or primed CD8+ T cells as in Fig. 4A underwent intravital imaging on day 7 p.i. (n = 3 mice/
group). Representative snapshots show (A) nil, (B) moderate and (C) severe levels of monocyte accumulation in the blood vessels. Scale bars
represent 60 mm. Migratory paths of monocytes are shown as purple tracks. Blood vessels are marked by infusion of TRITC-conjugated dextran. White
arrows indicate direction of blood flow. (D) % blood vessels with nil, moderate and severe levels of monocyte accumulation in MacGreen6RAG2/2
and MacGreen mice. Average number of (E) adherent and (F) rolling leukocytes per mm2 of endothelium. A total 46, 123, 82 and 104 blood vessels
were assessed for recipients of saline, CD82 splenocytes, naı¨ve and primed CD8+ T cells respectively. Number of vessels assessed per mouse: saline
(n = 10, 12, 24), CD82 splenocytes (n = 45, 28, 25), naive CD8+ T cells (n = 60, 11, 11), primed CD8+ T cells (n = 49, 33, 22). Blood vessel numbers for
MacGreen mice are as in Fig. 2. Data are a mean of 2–3 independent experiments. Bars represent mean 6 SEM, ns, not significant, *p,0.05, **p,
0.001, ***P = 0.0001 (ANOVA, Tukey’s multiple comparisons test).
doi:10.1371/journal.ppat.1004236.g005
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obstruction was unlikely to be a reason for the decreased velocity
as we assessed only blood vessels that supported high velocity, free
flowing cells [57]. In support of our view, recent reports have
shown that a decrease in the velocity of circulating pRBC during
ECM is rarely accompanied by vascular occlusion [59]. However,
it should be pointed out that we did not directly correlate red
blood cell (RBC) velocities and rolling behaviour of monocytes.
Thus it is conceivable that in severely inflamed blood vessels a
decrease in blood flow may have contributed to the observed
reduction in the velocity of rolling monocytes [59].
To understand the cellular mechanism that regulates monocyte
behaviour, we set up an adoptive transfer model. Primed CD8+ T
cells transferred from PbA-infected mice were mostly differentiat-
ed effector cells (data not shown and [13,52]) that had a T cell
repertoire specific to Plasmodium antigen. We found that, following
adoptive transfer, CD8+ T cells promoted monocyte adhesion to
the vascular endothelium and led to a significant decrease in the
rolling velocity of monocytes. Primed T cells were more effective
than CD82 splenocytes or naı¨ve T cells in promoting monocyte
adhesion, slowing down rolling monocytes and inducing disease
and this coincided with a significant number of primed CD8+ T
effector cells being recruited to the brain (not shown). These data
are in line with reports of CD8+ T cell recruitment to and
activation of CTL function in the CNS vasculature leading to
inflammation and disease [16,21,24,60,61]. Further, primed T
cells induced ECM in MacGreen6RAG2/2 recipient mice within
the same time frame as wild type MacGreen mice suggesting that
primed T cells, unlike naı¨ve T cells, can be recruited directly to the
brain while bypassing the requirement for priming. Furthermore,
uninfected recipients that received primed CD8+ T cells did not
develop ECM (data not shown), suggesting a requirement for
Plasmodium antigen at the effector phase, as reported [21,24,62].
While the recruitment of CD8+ T cells to the brain during ECM
is dependent upon IFNc driven production of the CXCR3-
binding chemokines CXCL9 and CXCL10 [16,44,60], the origin
of this IFNc is debated. Either NK cells [63] or CD4+ T cells
[64,65] have been proposed to be the cellular source of this critical
IFNc. In our hands, transfer of purified primed CD8+ T cells into
infected RAG-12/2 recipients (which retain NK but lack CD4+ T
cells) resulted in the development of ECM. These data echo those
of Nitcheu et al., who transferred CD8+ T cells of .98% purity
into RAG-22/2 mice and demonstrated the capacity of CD8+ T
cells to drive neuropathology and disease in the absence of CD4+
T cells [13]. Similarly, we found that transfer of OT-I effector cells
(.98% purity) into RAG2/2 recipient mice infected with OVA-
transgenic parasites (PbTG) led to disease, as reported (data not
Figure 6. Effect of monocyte depletion on the development of ECM. (A) Mice were infected with PbA and administered with CL or sham-
treated (PBS) i.v., at the indicated times. Survival time to a predetermined clinical endpoint is shown. (B) Histopathological scores of brain sections
from mice in panel A. *p,0.05 (Mann-Whitney test vs. PBS control). (C) Effect of CL treatment on brain leukocyte populations. Uninfected (UI) or
infected (PbA) mice were treated with CL or PBS on day +5 p.i., sacrificed on developing ECM (day 6), and the indicated BSL populations were
quantified by flow cytometry. Symbols represent individual animals and bars the geometric mean. **P,0.01, ***p,0.001 (ANOVA on log-transformed
data with Tukey’s post-test). Data are pooled from two independent experiments (A, C) or a single experiment (B). NK cell data are from a single
experiment.
doi:10.1371/journal.ppat.1004236.g006
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shown and [24]). Nevertheless a small number of CD4+ T cells
were recruited to the brain of mice that developed NS (primed
CD8+ T cell recipients) as well as in mice that were protected from
disease (CD82 splenocyte recipients) therefore we can not formally
exclude that small numbers of CD4+ T cells contributed to CD8+
T cell recruitment.
Although some studies have suggested that monocytes are
essential for the induction of ECM [66,67], others have argued
that these cells are dispensable [68]. We addressed the role of
monocytes by administration of CL. Since CL administration does
not result in complete depletion, unequivocal conclusions about
the functional role of these cells could not be drawn at this stage;
however our data did reveal an influence of phagocytic cells,
including monocytes, in both early and late processes underlying
ECM. Depletion prior to infection resulted in diversion of the
disease course away from cerebral pathology. This observation is
consistent with involvement of a phagocytic population in
induction of immune processes that normally culminate in
ECM. The most likely phagocytic population is Clec-9a+ DCs
that are responsible for cross-presentation of Plasmodium antigens to
CD8+ T cells [69]. When monocytes were depleted by CL
administration late in the course of infection, there were significant
decreases in sequestered CD8+ T, as well as CD4+ T and NK cells
within the brain compared to sham depleted controls. Consistent
with monocyte contribution to this process, we have previously
shown that, during ECM, cells sequestered within the vasculature
express CXCL9 mRNA [44]. Nevertheless, monocyte depletion
did not alter the course of disease progression. This phenomenon
is potentially explained by results from our adoptive transfer model
where we found that recruitment of a very small number
(,35,000) of CD8+ T cells recruited to the brain is sufficient to
induce neuropathology (not shown). Thus although monocytes
contribute to CD8+ T cell recruitment, in their absence sufficient
T cells are still recruited to the brain to initiate ECM.
Although monocytes themselves were not essential to ECM
pathology, their recruitment to the brain vasculature appeared to
be a sensitive readout that correlated with end stage pathological
processes. Our adoptive transfer model enabled us to track
precisely how primed CD8+ T cells regulated monocyte trafficking
in the microvasculature of the brain during disease. We found that
even a small increase in the numbers of severely inflamed venules
(17% increase in mice that received primed T cells as compared to
naive T cells) was associated with a strikingly different clinical
outcome (Fig. 5D). Thus monocyte accumulation served as a
useful surrogate marker for visualising the unfolding of vascular
inflammation in the CNS. Altogether our data support the view
that NS manifestation correlates with CD8+ T effector cells
promoting a critical threshold of monocyte accumulation in the
venules. To this end, a critical number of CD8+ T effector cells
were required to attain this threshold. The underlying molecular
mechanism/s by which CD8+ T cells promote monocyte
accumulation are unclear; however specific blockade of LIGHT-
LTbR interactions during PbA infection was shown to decrease
monocyte sequestration in the brain [70]; a potential role for
LIGHT or LT-alpha/beta expressed on activated CD8+ T cells
[71] can therefore be envisaged in facilitating monocyte sequestra-
tion. Similarly, IFNc along with TNF and LT-alpha is a candidate
cytokine that can promote monocyte sequestration by increasing the
expression of adhesion molecules such as ICAM-1, VCAM-1, P-
selectin and E-selectin on mouse brain endothelial cells [72].
Altogether, our observations are consistent with a model in which
damage to the blood-brain barrier (BBB) and vascular leakage
caused by CD8+ T cell-mediated cellular/molecular factors is
ultimately responsible for disease and death during ECM [59,73].
Materials and Methods
Ethics statement
This study was carried out in accordance with the guidelines
from The National Health and Medical Research Council of
Australia. All animal procedures were carried out under the
protocol number K75/11-2009/3/5195, approved by the Uni-
versity of Sydney Animal Ethics Committee. All mice were
maintained with environmental enrichment in specific pathogen-
free (SPF) conditions at the Centenary Institute Animal Facility.
The surgical procedures and intravital imaging experiments were
carefully optimised [27] and performed by trained specialists. The
anaesthetic drugs Ketamine, Xylazine and Buprenorphine were
used for anaesthetising mice prior to surgery.
Mice
All mice used in this study were on a C57BL/6 background.
Lysozyme-GFP mice [74], and c-fms-GFP (MacGreen) mice
[30,31] were described previously. C57BL/6 and RAG-12/2
mice were obtained from the Australian Resource Centre (ARC)
[75]. Wildtype MacGreen+/+ were outcrossed with RAG-12/2
mice to derive F1 MacGreen6RAG+/2 heterozygous mice.
Heterozygous parents were intercrossed to derive MacGreen6
RAG2/2 homozygotes. Litters underwent prior screening for GFP
and CD3 (Fig. S11A) as well as B220 expression by flow cytometry
and for RAG-1 gene expression by PCR (Fig. S11B). Only CD32
GFPhi MacGreen6RAG2/2 mice were used in this study.
Parasites and infections
PbA strain was maintained and used as previously reported
[76]. All wildtype, transgenic and knockout mice were infected
intraperitoneally (i.p.) with 106 pRBC. Parasitemia was deter-
mined by thin blood smears prepared from tail bleeds. Smears
were stained using the Diff-Quick kit (Lab Aids, Narrabeen, NSW,
Australia).
Clinical disease assessment
PbA-infected MacGreen mice that developed minor clinical
signs were referred to as being in the early stage or ES (Fig. S1). ES
was defined by reduced activity, hair standing on end, prominent
vertebral spinous processes/scapulae/pelvis, sunken eyes and/or
hunched posture. Each minor clinical sign was given a score of 1
with mice receiving a maximum ES score of 2. Mice with $3
minor clinical signs on days 1–6 p.i. were euthanized in
accordance with ethics guidelines and given a maximum score
of 8 the following day to denote death. Mice were allowed to
develop severe clinical signs on day 7 p.i. defined by ataxia,
immobility, isolation from group, reduced searching behaviour,
muscular weakness, hemiparesis, paraparesis, inability to grab the
cage grid and/or hold on to a rope, fitting, inability to roll and/or
spasmodic backbend (Fig. S1). These mice were referred to as
having neurological signs or NS. Each severe clinical sign was
given a score of 1 with mice receiving a maximum NS score of 8.
All mice in the experimental study were sacrificed at the pre-
defined clinical end-point of day 7 p.i. A modified clinical scoring
system was used for monocyte depletion experiments, with animals
being euthanized if they manifested with any of the following signs:
decreased stimulated movement with unsteady gait, hemiplegia,
seizures or inability to grab the cage grid.
Antibodies and reagents
Fluorochrome-labelled antibodies were purchased from BD
Biosciences and Biolegend and included anti-CD3, CD4, CD8,
CD11b, CD19, CD45, CD335, NK1.1, B220, F4/80, Ly6C and
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Ly6G (Table S2). For in vivo labelling, WGA-A594 (Life
Technologies) was administered i.v. in mice just prior to sacrifice.
Mice were perfused intracardially and brains were harvested.
Similarly one hour prior to intravital imaging, 5 mg of anti-Ly6C,
Ly6G or isotype antibody (Biolegend) was administered i.v. in mice
via the lateral tail vein to label cells in vivo. CL containing 5 mg/ml
clodronate were purchased from www.clodronateliposomes.com.
Monocytes were depleted by a single i.v. injection of 200 ml of CL
on the day indicated in the main text.
Sample preparation for flow cytometry
To purify leukocytes from the brain, mice were sacrificed and
perfused via the heart with 20 ml of perfusion fluid (0.05% w/v
EDTA in ice cold PBS) to remove blood contaminants and non-
sequestered cells from the cerebral vasculature. Brains were
initially mashed between frosted glass slides in PBS. Subsequently,
they were digested with collagenase type IV (Sigma) and DNase I
(Sigma) for 20 min at room temperature, and triturated through a
Pasteur pipette before a second 20 min collagenase/DNase
incubation. Low-density dead cells/debris/myelin were removed
by resuspension in 30% Percoll and centrifugation at 500 g for
10 min at 4uC. Contaminating RBCs were then lysed using Tris-
ammonium chloride buffer and leukocytes were washed and
enumerated. To process brains harvested from RAG2/2 mice,
whole brains weighing up to 600 mg were placed in 2650 ml of
PBS containing 0.05% v/v FCS, collagenase type IV (2 mg/ml)
and DNAse I (0.5 mg/ml). For brains weighing more than
600 mg, suspension volume was scaled up accordingly. Brains
were homogenized using a gentleMACS dissociator (Miltenyi).
Tissue suspension was digested by rotational mixing at 37uC for
60 min and, after a wash, debris/myelin were removed by Percoll
centrifugation as above. For flow cytometry on blood leukocyte
populations, 20 ml of blood was collected from the tail using
EDTA as an anticoagulant and red blood cells lysed using Tris-
ammonium chloride buffer. Following lysis, cells were washed and
stained as described below.
Flow cytometric analysis
Cells obtained from the brain were suspended in 2% (v/v) FCS
in PBS (FACS wash buffer containing 2 mM EDTA and 0.01%
w/v sodium azide) containing anti-CD16/32 (2.4G2) (BD) to
block Fc receptors. Cells were stained by incubating with
fluorochrome-labelled antibodies diluted in FACS buffer for
30 min on ice. Thereafter, cells were washed and stained with
0.5 mg/ml DAPI (Invitrogen) for dead cell exclusion. For blood
leukocyte counts, samples were spiked with a known concentration
of Accucount polystyrene microspheres (Spherotech, Lake Forest,
Illinois) to determine absolute numbers of cells in the original
sample. Data were acquired on a FACS Canto II (BD),
LSRFortessa (BD) or LSR-II flow cytometer (BD) and analysed
using FlowJo software (Treestar).
T cell isolation
All cell isolations were performed in a biological safety cabinet under
sterile conditions to facilitate transfer into immunodeficient mice.
CD8+ T cells were positively selected from disaggregated splenocytes
using CD8-conjugated immunomagnetic beads (Miltenyi) and MACS
columns (Miltenyi). Positive fractions were further enriched by passing
cells through a second MACS column as suggested by the
manufacturer. Approximately 80% of the cells in the positive fraction
were enriched for CD3+CD8+ T cells as assessed by flow cytometry.
Approximately 5% of the CD82 splenocytes constituted CD3+CD8+ T
cells that had eluted into the negative fraction.
Adoptive T cell transfer
MacGreen6RAG2/2 recipient mice aged 5–8 weeks were first
infected with 106 pRBC via the i.p. route. CD8+ T cells isolated by
MACS positive selection and CD82 splenocytes constituting the
negative fraction were adoptively transferred into recipient mice
4–6 hours later. Either 36106, 4.56106 or 107 cells were
administered into the tail vein. PbA-infected mice were monitored
as above.
Immunohistochemistry
Mice were administered WGA-A594 i.v., just prior to sacrifice.
Vascular perfusion was performed as above using 10% neutral
buffered formalin (Sigma) in PBS. Brains were harvested and
further fixed in 10% neutral buffered formalin and 4% w/v
sucrose for 16 hours at 4uC. Longitudinal or superior transverse
sections of the brain were prepared using a vibratome and then
blocked in 10% FCS. Immunohistochemistry was performed by
treating brain sections with anti-Ly6C, anti-Ly6G or anti-F4/80
antibody. For some sections, blood vessels were stained with
purified anti-CD31 antibody, which was conjugated to Alexa594
using the monoclonal antibody labelling kit (Life Technologies).
Both WGA-A594 and CD31 delineated the blood vessels. Sections
were mounted in mounting medium (DAKO) and a series of single
Z-stack images were acquired by confocal microscopy using a 206
dry or 636 oil objective (Leica SP5). Image analysis was done
using Volocity (Perkin-Elmer).
Histopathological scoring
The presence of typical histopathological features of ECM was
determined in paraffin embedded haematoxylin and eosin stained
brain sections. Slides were scored in a blinded manner for 3
features: (1) the presence of sequestered cells in the vasculature, (2)
tissue oedema and (3) haemorrhages. Each feature was scored
from 0–3: 0 = not present; 1 = isolated (1–2) occurrences through-
out a single brain section; 2 = 2–4 occurrences; 3 =.4 occurrenc-
es. Values for each feature were added to provide a single
histopathological score.
Cranial window preparation
Mice were prepared for intravital imaging of the brain as
previously described [27]. Briefly, animals were anaesthetised by
i.p. injection of Ketamine (100 mg/kg of body weight) (Cenvet)
and Xylazine (10 mg/kg of body weight) (Cenvet). Buprenorphine
(Cenvet) was administered at 100 mg/kg of body weight i.p. for
lasting pain relief. Animals were monitored for awareness signs
such as whisker twitching, palpebral (blink) reflex, pedal
withdrawal reflex and respiration rate, and surgical procedures
were initiated only after the animal entered a deep state of
anaesthesia (Table S1). A primary dose of Ketamine/Xylazine
mixture was given increased time for anaesthetic action (3 times
longer than healthy mice) and a booster dose was administered
only after this time. Importantly, anaesthetic strategy was
individually tailored to each mouse—for example, mice with
paraparesis (partial paralysis in the lower limbs) were expected to
take 3 times as long as healthy mice to lose their pedal-withdrawal
reflex. Loss or regain of reflexes was closely monitored throughout
the procedure and booster doses of Ketamine and Xylazine were
administered as required.
Anaestethized mice were placed on a heat pad (Fine Science
Tools) and core body temperature was monitored using a rectal
probe (Fine Science Tools), as described [27]. The head of the
mouse was restrained in a stereotaxic frame, and the skull was
exposed by making a mid-line incision in the scalp. The
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periosteum was removed and a circular incision was made in the
parietal bone using a pneumatic dental drill to yield a cranial flap.
The flap was lifted gently without damaging the dura mater
underneath. Minor bleeding was controlled using gelfoam bits and
the cranial window was bathed in pre-warmed artificial cerebro-
spinal fluid (aCSF) (132 mM NaCl, 2.95 mM KCl, 1.71 mM
CaCl2.2H20, 1.4 mM MgSO4, 6.7 mM Urea, 24.6 mM
NaHCO3, 3.71 mM glucose, pH 7.4) [27]. The chamber was
sealed with a coverslip held in place with vacuum grease.
2-photon intravital microscopy
All the intravital imaging experiments in this study were
performed for up to 1.5 hours, as described previously [27].
Where extended recordings of more than 1.5 hours are required,
we recommend the addition of a superfusion chamber containing
aCSF as shown in Fig. S3 [27]. Imaging was performed using a
LaVision Biotec Trimscope II single-beam 2-photon microscope
(Bielefeld, Germany) attached to an Olympus BX-51 fixed-stage
microscope equipped with 206 (NA0.8) water-immersion objec-
tive. The setup included external non-descanned dual-channel/
fluorescence detectors and a diode-pumped, wide-band mode-
locked Ti:Sapphire femtosecond laser (MaiTai HP; Spectraphy-
sics, 720–1050 nm, pulse length 140 fs; 90 MHz repetition rate).
To label blood vessels, 800 mg of TRITC-conjugated dextran
(Invitrogen) dissolved in saline or Evans blue conjugated to BSA
was injected i.v. just prior to imaging. For data acquisition, firstly a
suitable field of view was selected in the upper left region of the
cranial window. The brain was exposed to polarized laser light at a
wavelength of 900 nm, and x-y-t data of a 300 mm6300 mm plane
at a resolution of 0.6 mm pixel21 was captured at the rate of 1
frame per second. A minimum 120 to a maximum 600 frames
were collected and sometimes combined with 3-dimensional z
stacks to create x-y-z-t time-lapse images. The next field of view
was recorded by moving horizontally across to the next
300 mm6300 mm plane within the cranial window. Only fields
of view with at least 1 blood vessel were recorded. A minimum 29
to a maximum 123 blood vessels were assessed for each group of
mice.
Data analysis
Post-acquisition image analysis was carried out using Volocity
software. Firstly, each blood vessel was annotated with a unique
identity code. For the analysis of leukocyte behaviour, each blood
vessel was initially assessed for intact blood flow present for the
entire duration of the recording. Intact blood flow was defined by
the presence of high velocity, freely flowing leukocytes (at least one
free flowing cell during the observation period). The area of each
blood vessel was derived by measuring its length and diameter.
The phenotype of the blood vessels and its tributaries were
assessed for brightness, size, central reflex, wall thickness and
direction of flow [77]. As relying solely on phenotypic features can
lead to misclassification of arteries and veins, we used a functional
parameter that is widely utilised to distinguish the two. Diverging
vessels with outflow of blood were classified as arteries and
converging vessels with inflow of blood were classified as veins.
Data were collated only from large post capillary venules.
Leukocytes were tracked as they entered the field of view and
over the entire observation period. Rolling cells were defined as
single, round-shaped cells moving in the direction of the blood
flow at a lower speed than free flowing cells. Adherent cells were
defined as single cells that remain stationary for 30 seconds or
longer. To normalise for variability in blood vessel diameter, the
average number of rolling cells per mm2 of blood vessel over a
period of 1 min and the number of adherent cells per mm2 of
blood vessel were calculated. The mean rolling velocity (Vmean) of
leukocytes was defined as the distance travelled by rolling cells per
second. The percentage of blood vessels within the cranial window
with varying degrees of leukocyte infiltration, as defined in results
below, was calculated.
Statistical analysis
Differences in survival of treatment groups were analysed using
the Mantel-Cox log-rank test. Correlations were calculated and
plotted using Prism (Graphpad Prism software). For comparison of
two groups, the Student’s t-test (normally distributed) or the
Mann-Whitney U test (not normally distributed) were used. For
multiple comparisons, one-way ANOVA was used. A difference
between groups was considered significant if p,0.05.
Supporting Information
Figure S1 Schematic depicts the progression of clinical
disease during ECM. The progression of clinical signs from ES
to NS is shown.
(TIF)
Figure S2 Relative percentages of BSL. Uninfected and
PbA-infected C57BL/6 mice with NS were sacrificed on day 7 p.i.,
and vascular perfusion was performed. (A) Gating strategy shows
neutrophils (CD45hi, autofluorescence (AF)lo, Lin2, CD11b+,
Ly6Ghi) and inflammatory monocytes (CD45hi, AFlo, Lin2,
CD11b+, Ly6G2, Ly6Chi) in the brains of uninfected and PbA-
infected animals. (B) Gating strategy shows CD4+ T cells (CD45hi,
AFlo, CD3+, CD4+) and CD8+ T cells (CD45hi, AFlo, CD3+,
CD8+) as well as NK cells (CD45hi, AFlo, CD32, CD335+,
NK1.1+) (C) Monocytes, neutrophils, CD8+ T cells, CD4+ T cells
and NK cells expressed as a percentage of the total CD45hi brain
leukocyte population pre- and post-PbA infection. Cells were
harvested on day 7 p.i. when mice had ECM (n = 5 mice/group).
(TIF)
Figure S3 Brain imaging model for ECM. Picture depicts
head restraint within the stereotaxic frame, cranial window
preparation and a superfusion chamber that can be used for
extended recordings of .1.5 hours.
(TIF)
Figure S4 GFP+ leukocytes sequestering to the vascular
endothelium are monocytes. PbA-infected MacGreen mice
with NS were sacrificed and brains were harvested. Whole mount
brain sections were treated with anti-Ly6C or anti-Ly6G
antibodies. Anti-CD31 antibodies were used for delineating the
blood vessels. A series of single z-stack images were acquired by
confocal microscopy. A representative single z-stack image shows
the co-localisation of Ly6C but not Ly6G with GFP. Scale bars
represent 10 mm.
(TIF)
Figure S5 Locomotion pattern of monocytes during
clinical progression of ECM. (A) Quantitative analysis of
the mean track velocity of monocytes during ES on day 5–6 p.i.
(n = 5 mice) and (B) NS on day 7 p.i. (n = 3 mice). The speed at
which monocytes travel per second in the blood vessel (instanta-
neous velocity) was calculated for (C) ES on day 5–6 p.i. and (D)
NS on day 7 p.i. Three representative monocyte tracks are shown
for each group. (E) Comparison of the Vmean of GFP
+ monocytes
in moderately and severely inflamed venules. Calculations were
derived from 125 and 20 cell tracks. ****P,0.0001 (Mann-
Whitney U test).
(TIF)
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Figure S6 Monocytes do not extravasate during ECM.
(A) Representative snapshot of monocytes rolling unidirectionally
with blood flow (white arrows) during ES (n = 5 mice). Scale bar
30 mm. Path of monocytes are shown as purple tracks. (B)
Individual cell tracking analysis plotted with each cell’s start
position at the origin and its movement along the x–y axis. (C) MI
of GFP+ monocytes during ES (n = 5 mice) and NS (n = 3 mice).
Calculations were derived from 126 and 23 cell tracks respectively.
ns, not significant, Data are a mean of 3–5 independent
experiments. (D) Groups of PbA-infected MacGreen6RAG2/2
recipient mice as in Fig. 4A were injected WGA-A594 i.v. just
prior to sacrifice and then perfused intracardially. Brain sections
were prepared. A series of single z-stack images of blood vessels
with monocyte accumulation were acquired by confocal micros-
copy (n = 4 mice). Panel (i) The vascular lumen (outlined) is
mostly devoid of F4/80+ cells (blue). Panel (ii) Monocytes
marked bright red from WGA-A594 staining are F4/802 or F4/
80lo. Panel (iii) Circular GFP+ intravascular monocytes (yellow
overlay) are F4/802 or F4/80lo (red arrowhead) whereas GFP+
perivascular cells (blue-green overlay) are mostly F4/80+ (yellow
arrowhead). Scale bars 59 mm.
(TIF)
Figure S7 Low monocyte accumulation in the brain
microvasculature of PbA-infected MacGreen6RAG2/2
mice. MacGreen6RAG2/2 mice were infected with PbA and
intravital imaging was performed. (A) Representative snapshots of
blood vessels. Scale bar 44 mm. (B) % blood vessels that have nil,
moderate and severe levels of monocyte accumulation. (C)
Average number of rolling and adherent monocytes per mm2 of
endothelium min21. Bars represent mean 6 SEM. ****P,0.0001
(Mann Whitney U test), (n = 3–4 mice/group). Data are a mean of
2–3 independent experiments.
(TIF)
Figure S8 Comparison of the Vmean of monocytes in
inflamed venules. Moderately and severely inflamed venules
from MacGreen6RAG2/2 mice that received CD82 splenocytes,
naı¨ve CD8+ T and primed CD8+ T cells were pooled and assessed.
Calculations were derived from 97 and 127 cell tracks respectively.
****p,0.0001 (Mann-Whitney U test), (n = 7 mice/group). Data
are a mean of 6 independent experiments.
(TIF)
Figure S9 Dose-dependent effect of primed CD8+ T cells
on clinical disease. Primed CD8+ T cells (10, 4.5, 3 or 06106)
were adoptively transferred into PbA-infected MacGreen6
RAG2/2 recipient mice (n = 2–3 mice/group) and intravital
imaging was performed on all groups on day 7 p.i. (A) survival and
(B) % blood vessels with nil, moderate and severe levels of
leukocyte accumulation are shown. A total 104, 62, 70 and 46
blood vessels were assessed for recipients of 106106, 4.56106,
36106 and 06106 primed CD8+ T cells respectively, with the
following assessed per mouse: 106106 (n = 49, 33, 22), 4.56106
(n = 39, 23), 36106 (n = 37, 33) and 06106 (n = 10, 12, 24). Data
are a mean of 2–3 independent experiments.
(TIF)
Figure S10 Effect of monocyte depletion on the devel-
opment of ECM – infection parameters. Mice were infected
with PbA and administered with CL or sham-treated (PBS) i.v. at
the indicated times. (A) Haematocrit and (B) Parasitemia are
shown.
(TIF)
Figure S11 Genotyping profile of MacGreen6RAG2/2
mice. (A) Pre-screening of peripheral blood leukocytes by flow
cytometry shows the expression of GFP in the CD32 fraction in
both MacGreen6RAG+/2 and MacGreen6RAG2/2 mice.
CD3+ T lymphocytes are seen in heterozygous but not in
homozygous mice (B) Total DNA extracted from peripheral
blood was analysed for RAG-1 expression by PCR. RAG+/2 mice
express wildtype RAG as well as mutant RAG (Lane 2) whereas
RAG2/2 mice express only mutant RAG (Lane 3).
(TIF)
Table S1 Anaesthesia monitoring sheet.
(DOCX)
Table S2 List of antibodies.
(DOCX)
Movi S1 Nil leukocyte accumulation in the brain
microvasculature. A representative time-lapse sequence of an
x–y plane shows the motility pattern of GFP+ leukocytes (green) in
a non-inflamed blood vessel of uninfected MacGreen mice. Blood
vessel is marked by infusion of TRITC-conjugated dextran (red).
Perivascular myeloid cells line the blood vessels. GFP+ leukocytes
flowed rapidly through the blood vessel appearing as ‘streaks’ and
rarely interacted with the vascular endothelium. Leukocyte
accumulation levels in such non-inflamed blood vessels (0–300
cells mm2 min21) were graded as nil accumulation. This video as
well as all others run at 1 frame/sec. Elapsed time is shown in
hh:mm:ss.
(MOV)
Movie S2 Moderate leukocyte accumulation in the
brain microvasculature. A representative time-lapse sequence
of an x–y plane shows moderate levels of leukocyte accumulation
in the brain microvasculature of PbA-infected MacGreen mice
(300–1000 cells mm2 min21).
(MOV)
Movie S3 Severe leukocyte accumulation in the brain
microvasculature. A representative time-lapse sequence of an
x–y plane shows severe levels of leukocyte accumulation in the
brain microvasculature of PbA-infected MacGreen mice (.1000
cells mm2 min21).
(MOV)
Movie S4 GFP+ leukocytes sequestering to the brain
microvasculature are not stained by isotype control
antibody. A time-lapse sequence of an x–y plane depicts GFP+
leukocytes in the brain microvasculature of PbA-infected Mac-
Green mice with NS. An Alexa647-conjugated isotype antibody
was infused i.v. one-hour prior to start of recording. GFP+
leukocytes (green) did not take up any stain. White lines delineate
blood vessels. Blue signals represent SHG from the collagen fibres
in the brain parenchyma. Elapsed time is shown in hh:mm:ss.
(MOV)
Movie S5 GFP+ leukocytes interacting with the brain
vascular endothelium express Ly6C. A representative time-
lapse sequence of an x–y plane depicts GFP+ leukocytes in the
brain microvasculature of PbA-infected MacGreen mice with NS.
An Alexa647-conjugated Ly6C antibody was infused i.v. one-hour
prior to start of recording. Stationary leukocytes have an orange
punctate stain that overlay with GFP. Several rolling leukocytes
also stained for Ly6C. White lines delineate blood vessels. Blue
signals represent SHG from the collagen fibres in the brain
parenchyma. Elapsed time is shown in hh:mm:ss.
(MOV)
Movie S6 GFP+ leukocytes sequestering to the brain
microvasculature do not express Ly6G. A representative
Imaging Leukocyte Responses during Cerebral Malaria
PLOS Pathogens | www.plospathogens.org 14 July 2014 | Volume 10 | Issue 7 | e1004236
time-lapse sequence of an x–y plane depicts GFP+ leukocytes in
the brain microvasculature of PbA-infected MacGreen mice with
NS. An Alexa647-conjugated Ly6G antibody (red) was infused i.v.
one-hour prior to start of recording. Leukocytes (green) did not
take up any stain. White lines delineate blood vessels. Elapsed time
is shown in hh:mm:ss.
(MOV)
Movie S7 Rolling leukocytes in the dermal vasculature
are not stained by isotype control antibody. A represen-
tative time-lapse sequence of an x–y plane depicts GFP+ leukocytes
(green) rolling in the dermal vessels of uninfected Lysozyme-GFP
mice. An Alexa647-conjugated isotype antibody (red) was infused
i.v. one-hour prior to start of recording. Leukocytes did not take
up any stain. White lines delineate blood vessels. Elapsed time is
shown in hh:mm:ss.
(MOV)
Movie S8 Rolling leukocytes in the dermal vasculature
express Ly6C. A representative time-lapse sequence of an x–y
plane depicts GFP+ leukocytes rolling in the dermal vessels of
uninfected Lysozyme-GFP mice. An Alexa647-conjugated Ly6C
antibody (red) was infused i.v. one-hour prior to start of recording.
Leukocytes (green) show an orange punctate stain. White lines
delineate blood vessels. Elapsed time is shown in hh:mm:ss.
(MOV)
Movie S9 Rolling leukocytes in the dermal vasculature
express Ly6G. A representative time-lapse sequence of an x–y
plane depicts GFP+ leukocytes (green) in the dermal vessels of
uninfected Lysozyme-GFP mice. An Alexa647-conjugated Ly6G
antibody (red) was infused i.v. one-hour prior to start of recording.
A large number of leukocytes show a deep-red surface stain. White
lines delineate blood vessels. Elapsed time is shown in hh:mm:ss.
(MOV)
Movie S10 Rolling Monocytes do not exhibit extravasa-
tion. A representative time-lapse sequence of an x–y plane shows
rolling monocytes (green) in MacGreen mice 7 days p.i. Rolling
monocytes were unidirectional and did not extravasate from the
blood vessels. For visual clarity, blood vessels are not marked.
Elapsed time is shown in hh:mm:ss.
(MOV)
Movie S11 Monocyte accumulation levels in Mac-
Green6RAG2/2 mice following saline transfer. A repre-
sentative time-lapse sequence of an x–y plane shows the brain
microvasculature in PbA-infected MacGreen6RAG2/2 mice 7
days post transfer of saline. Blood vessels are marked by infusion of
TRITC-conjugated dextran. Monocytes flowed rapidly through
the blood vessel appearing as ‘streaks’ and rarely interacted with
the vascular endothelium. Saline transfer resulted in mostly nil
accumulation (0–300 mm2 min21). Elapsed time is shown in
hh:mm:ss.
(MOV)
Movie S12 Moderate monocyte accumulation levels in
MacGreen6RAG2/2 mice. A representative time-lapse se-
quence of an x–y plane shows moderate levels of monocyte
accumulation in the brain microvasculature of PbA-infected
MacGreen6RAG2/2 mice 7 days post-transfer of CD8+ T cells
(300–1000 cells mm2 min21).
(MOV)
Movie S13 Severe monocyte accumulation levels in
MacGreen6RAG2/2 mice. A representative time-lapse se-
quence of an x–y plane shows severe levels of monocyte
accumulation in the brain microvasculature of PbA-infected
MacGreen6RAG2/2 mice 7 days post-transfer of CD8+ T cells
(.1000 cells mm2 min21).
(MOV)
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